Announced

Baird Capital to invest $32m in Azzur Group.

Synopsis

Baird Capital, a venture capital, growth equity and private equity investment firm, is set to invest in Azzur Group, a pharmaceutical, biotechnology, and medical device manufacturer, for $32m. “Baird Capital has a history of investing in pharma services businesses, and we look forward to bringing our resources, relationships, and experiences to support Azzur’s future growth. We are excited to partner with Michael and his strong leadership team to help them build on their past successes," Brett Tucker, Baird Capital Partner.

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US